Important TB drug as effective at lower dose, study finds

The treatment of drug-resistant forms of tuberculosis (DR-TB) has been transformed over the last decade with treatment becoming more effective, safer, and treatment duration in many cases dropping to under a year.
Even so, treatment can still come with serious side effects and for some, it can still last over a year and a half and involve taking many different pills every day.
In a finding that may help further reduce side effects, new research has found that the dosage of the drug linezolid can be lowered without compromising how well it works. Together with another drug called bedaquiline, linezolid has been responsible for much of the recent progress.

Related Keywords

South Africa ,Georgia ,United States ,Groote Schuur ,Western Cape ,Russia ,University Of Cape Town ,Moldova ,South African ,Keertan Dheda ,Norbert Ndjeka ,Lindsay Mckenna ,Francesca Conradie ,World Health Organization ,Treatment Action Group ,African Health Products Regulatory Authority ,Division Of Pulmonology At Groote Schuur Hospital ,Society Conference ,Current World Health Organization ,National Clinical Advisory Committee ,Groote Schuur Hospital ,Cape Town ,South African Health Products Regulatory ,Action Group ,Principal Investigator ,ஜார்ஜியா ,ஒன்றுபட்டது மாநிலங்களில் ,மேற்கு கேப் ,ரஷ்யா ,பல்கலைக்கழகம் ஆஃப் கேப் நகரம் ,மோல்டோவா ,லிண்ட்சே மகெந ,உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,சிகிச்சை நடவடிக்கை குழு ,சமூகம் மாநாடு ,தற்போதைய உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,கேப் நகரம் ,நடவடிக்கை குழு ,ப்ரிந்ஸிபல் புலனாய்வாளர் ,